PLK1 and cancer: Transwell migration and invasion assays revealed that treatment with BI 6727 significantly reduced the motility and invasiveness of HeLa cells compared with DMSO-treated HeLa cells (Additional file 1: Fig. S2a and b), suggesting that PLK1 activity is critical for cancer cell migration and invasion.